Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.

R Barry Hird; Alfred Chang; Vincent Cimmino; Kathleen Diehl; Michael Sabel; Celina Kleer; Mark Helvie; Anne Schott; Jennifer Young; Daniel Hayes

doi:10.1002/cncr.21873

Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.

Identifier:nobleid.org/w1/20260515/39EE2BF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/39EE2BF7.svg?ark=w1%2F20260515%2F39EE2BF7)](https://nobleid.org/work/w1/20260515/39EE2BF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.

Identifier:nobleid.org/w1/20260515/39EE2BF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/39EE2BF7.svg?ark=w1%2F20260515%2F39EE2BF7)](https://nobleid.org/work/w1/20260515/39EE2BF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work